RADCQ has been successfully added to your Stock Email Alerts list.
You can manage your stock email alerts here.
RADCQ has been removed from your Stock Email Alerts list.
Please enter Portfolio Name for new portfolio.
Rite Aid's average Accounts Payable for the three months ended in Aug. 2023 was $1,467 Mil. Rite Aid's Cost of Goods Sold for the three months ended in Aug. 2023 was $4,550 Mil. Hence, Rite Aid's Days Payable for the three months ended in Aug. 2023 was 29.42.
The historical rank and industry rank for Rite Aid's Days Payable or its related term are showing as below:
During the past 13 years, Rite Aid's highest Days Payable was 35.58. The lowest was 23.36. And the median was 29.99.
Rite Aid's Days Payable increased from Aug. 2022 (28.58) to Aug. 2023 (29.42). It may suggest that Rite Aid delayed paying its suppliers.
The historical data trend for Rite Aid's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Rite Aid Annual Data | |||||||||||||||||||||
Trend | Feb14 | Feb15 | Feb16 | Feb17 | Feb18 | Feb19 | Feb20 | Feb21 | Feb22 | Feb23 | |||||||||||
Days Payable | Get a 7-Day Free Trial | 35.18 | 32.92 | 27.57 | 28.21 | 29.01 |
Rite Aid Quarterly Data | ||||||||||||||||||||
Nov18 | Feb19 | May19 | Aug19 | Nov19 | Feb20 | May20 | Aug20 | Nov20 | Feb21 | May21 | Aug21 | Nov21 | Feb22 | May22 | Aug22 | Nov22 | Feb23 | May23 | Aug23 | |
Days Payable | Get a 7-Day Free Trial | 28.58 | 27.74 | 27.78 | 30.59 | 29.42 |
For the Pharmaceutical Retailers subindustry, Rite Aid's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
For the Healthcare Providers & Services industry and Healthcare sector, Rite Aid's Days Payable distribution charts can be found below:
* The bar in red indicates where Rite Aid's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Rite Aid's Days Payable for the fiscal year that ended in Feb. 2023 is calculated as
Days Payable (A: Feb. 2023 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (A: Feb. 2022 ) | + | Accounts Payable (A: Feb. 2023 )) | / | count ) | / | Cost of Goods Sold (A: Feb. 2023 ) | * | Days in Period |
= | ( (1571.261 | + | 1494.611) | / | 2 ) | / | 19287.959 | * | 365 |
= | 1532.936 | / | 19287.959 | * | 365 | ||||
= | 29.01 |
Rite Aid's Days Payable for the quarter that ended in Aug. 2023 is calculated as:
Days Payable (Q: Aug. 2023 ) | |||||||||
= | Average Accounts Payable | / | Cost of Goods Sold | * | Days in Period | ||||
= | ( (Accounts Payable (Q: May. 2023 ) | + | Accounts Payable (Q: Aug. 2023 )) | / | count ) | / | Cost of Goods Sold (Q: Aug. 2023 ) | * | Days in Period |
= | ( (1505.741 | + | 1428.286) | / | 2 ) | / | 4550.485 | * | 365 / 4 |
= | 1467.0135 | / | 4550.485 | * | 365 / 4 | ||||
= | 29.42 |
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Thank you for viewing the detailed overview of Rite Aid's Days Payable provided by GuruFocus.com. Please click on the following links to see related term pages.
Christopher W. Dupaul | officer: Chief Operating Officer | 1200 INTREPID AVENUE, 2ND FLOOR, PHILADELPHIA PA 19112 |
Sabatino Thomas J Jr | officer: Chief Legal Officer | C/O JAN STERN REED BAXTER INTERNATIONAL, ONE BAXTER PARKWAY DF2 2W, DEERFIELD IL 60015 |
Steven Bixler | officer: Chief Accounting Officer | C/O RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011 |
Heyward R Donigan | officer: Chief Executive Officer | 452 DISCOVERY ROAD, VIRGINIA BEACH VA 23451 |
Jocelyn Z Konrad | officer: Executive VP | RITE AID CORPORATION, 30 HUNTER LANE, CAMP HILL PA 17011 |
Ray Smithberger | officer: SVP, Operations | 30 HUNTER LANE, CAMP HILL PA 17011 |
Bari A Harlam | director | C/O MOHAWK GROUP HOLDINGS, INC., 37 EAST 18TH STREET, 7TH FLOOR, NEW YORK NY 10003 |
Paul D Gilbert | officer: EVP, Secretary&General Counsel | 103 POWELL COURT, SUITE 200, BRENTWOOD TN 37027 |
Andre Persaud | officer: EVP, Retail | 30 HUNTER LANE, CAMP HILL PA 17011 |
Dan Robson | officer: President, EnvisionRXOptions | 30 HUNTER LANE, CAMP HILL PA 17011 |
James J Peters | officer: Chief Operating Officer | C/O NXSTAGE MEDICAL, INC., 350 MERRIMACK STREET, LAWRENCE MA 01843 |
James J Comitale | officer: EVP, General Counsel, Secy. | 30 HUNTER LANE, CAMP HILL PA 17011 |
Jessica Kazmaier | officer: EVP, Chief HR Officer | 30 HUNTER LANE, CAMP HILL PA 17011 |
Justin L. Mennen | officer: EVP, Chief Information Officer | 30 HUNTER LANE, CAMP HILL PA 17011 |
Katherine B Quinn | director | US BANCORP, 800 NICOLLET MALL, MINNEAPOLIS MN 55402 |
From GuruFocus
By sperokesalga sperokesalga • 05-19-2023
By GuruFocus Research • 08-25-2023
By Business Wire • 10-03-2023
By Business Wire • 10-10-2023
By GuruFocus Research • 08-28-2023
By Business Wire • 09-11-2023
By Business Wire • 10-06-2023
By Business Wire • 10-15-2023
By sperokesalga sperokesalga • 05-18-2023
By Business Wire Business Wire • 06-12-2023
Disclaimers: GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.